Prosecution Insights
Last updated: August 15, 2026
Application No. 18/734,147

CORN PROTEIN ISOLATE AND METHODS OF MANUFACTURING SAME

Non-Final OA §103
Filed
Jun 05, 2024
Priority
Mar 24, 2015 — provisional 62/137,526 +3 more
Examiner
TURNER, FELICIA C
Art Unit
Tech Center
Assignee
Cargill Incorporated
OA Round
1 (Non-Final)
26%
Grant Probability
At Risk
1-2
OA Rounds
1y 12m
Est. Remaining
56%
With Interview

Examiner Intelligence

Grants only 26% of cases
26%
Career Allowance Rate
167 granted / 636 resolved
-33.7% vs TC avg
Strong +30% interview lift
Without
With
+30.1%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
40 currently pending
Career history
697
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
61.5%
+21.5% vs TC avg
§102
8.8%
-31.2% vs TC avg
§112
24.6%
-15.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 636 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1, 2, 5, 6 and 9 are rejected under 35 U.S.C. 103 as being unpatentable over Takahashi et al. (USPN 5,367,055). Regarding Claims 1, 2, 5, 6: Takahashi discloses a process for treating a zein (corn protein) containing raw material, which forms an extracted and purified zein (corn protein isolate) product, wherein the treatment process involves removing color from zein (corn protein) [abstract; column 2, lines 16-24; see Examples 3-5]. In Examples 1 and 2, Takahashi discloses a zein (corn protein) isolate which can have an a* hue value of -0.8 and a b* hue value of 11.4 [column 3, Table 1], as well as an L* hue value of 94.3 [Table 2]. Takahashi discloses a protein content of the corn protein at about 91.2%, about 90.8%, about 96.7% [Ex. 3, 4, 5]. Takahashi discloses a clear/transparent or light yellow corn protein solution [Ex. 1, 2, 3]. Regarding a* color value of claims 1 and 5, the amounts are substantially close to that of the instant claims at about -0.5 to 1.5 and about 0.3 to 0.3, one of ordinary skill would have expected compositions that are in such close proportions to those in prior art to be prima facie obvious and to have same properties. Titanium Metals Corp., 227 USPQ 773 (CAFC 1985). Regarding Claim 9: Takahashi discloses as discussed above in claim 1. Takahashi does not disclose that the organic acid content is 4.25 g/kg or less. However, “Products of identical chemical composition cannot have mutually exclusive properties.” A chemical composition and its properties inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990). Claim 7 is rejected under 35 U.S.C. 103 as being unpatentable over Takahashi et al. (USPN 5,367,055) as applied to claim 1 above and in further view of Garbutt (US 4,018,936). Regarding Claim 7: Takahashi discloses as discussed above in claim 1. Takahashi does not disclose the oil content of the gluten meal. Garbutt discloses corn gluten that is treated and contains 0.13% or 0.44% fat [Ex. 8; col. 8, lines 1-7]. Garbutt discloses gluten treated to a higher purity level [abstract]. At the effective filing date of the invention it would have been obvious to one of ordinary skill in the art that the treated gluten of Takahashi would have contained a negligible amount of fat/oil lower than 1% as in Garbutt since the gluten is isolated from the corn kernel and is treated in a way to remove other constituents or to remove it from other constituents. Claim 8 is rejected under 35 U.S.C. 103 as being unpatentable over Takahashi et al. (USPN 5,367,055) as applied to claim 1 above and in further view of Stewart et al. (US 2557397). Regarding Claim 8: Takahashi discloses as discussed above in claim 1. Takahashi does not disclose the carbohydrate content of the corn gluten meal at 45g/kg or less (about 4.5% or less). Stewart discloses a carbohydrate content of 2% in a treated gluten meal [Ex. 3]. At the effective filing date of the invention it would have been obvious to one of ordinary skill in the art to that the treated corn gluten of Takahashi would have had carbohydrate content of less than 4.5% as in Stewart since the corn gluten is treated to produce a more purified protein product. Claim 10 is rejected under 35 U.S.C. 103 as being unpatentable over Takahashi et al. (USPN 5,367,055) as applied to claim 1 above and in further view of Anderson (USDA article provided by Applicant). Regarding Claim 10: Takahashi discloses as discussed above in claim 1. Takahashi does not disclose the aflatoxin content. Anderson discloses aflatoxin content in corn being reduced from 1000 ppb to less than 10 ppb [abstract]. At the effective filing date of the invention it would have been obvious to one of ordinary skill in the art to treat the corn gluten in Takahashi as in Anderson in order to provide corn gluten having an aflatoxin content of less than 1ppb. Although Anderson does not explicitly disclose 1 ppb or less one having ordinary skill in the art at the effective filing date of the invention would have considered the invention to have been obvious because the range taught by Anderson overlaps the instantly claimed range and therefore is considered to establish a prima facie case of obviousness. In re Malagari 182 USPQ 549,553. Claim 11 is rejected under 35 U.S.C. 103 as being unpatentable over Takahashi et al. (USPN 5,367,055) as applied to claim 1 above and in further view of JP 4750901. Regarding Claim 11: Takahashi discloses as discussed above in claim 1. Takahashi does not discloses the sulfite content at less than about 150 ppm. JP’901 discloses corn gluten containing sulfite at less than 30ppm [0007] . JP’901 discloses corn gluten meal as containing a high sulfite content and that it may cause problems in the health of people with sensitivity to chemical [0008]. At the effective filing date of the invention it would have been obvious to one of ordinary skill in the art to treat the corn gluten meal of Takahashi in a way to produce a lowered amount of sulfite/sulfur oxide especially where consumers have sensitivity to the compound. Conclusion 11. Any inquiry concerning this communication or earlier communications from the examiner should be directed to FELICIA C TURNER whose telephone number is (571)270-3733. The examiner can normally be reached Mon-Thu 8:00-4:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Emily Le can be reached at 571-272-0903. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Felicia C Turner/Primary Examiner, Art Unit 1793
Read full office action

Prosecution Timeline

Jun 05, 2024
Application Filed
Jul 29, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12690602
TRADITIONAL CHINESE MEDICINE POLYSACCHARIDE EXTRACT FREEZE-DRYING PROTECTIVE AGENT, DIRECT-TO-VAT STARTER AND PREPARATION METHODS THEREOF
3y 6m to grant Granted Jul 28, 2026
Patent 12642280
YEAST AND LACTIC ACID BACTERIA COMBINATION
3y 7m to grant Granted Jun 02, 2026
Patent 12628834
A BREAD WITH D-ALLULOSE INSTEAD OF SUCROSE AND A PREPARATION METHOD THEREFOR
2y 10m to grant Granted May 19, 2026
Patent 12604923
COMPOSITION FOR AEROZOL FOOD PRODUCT, HYDROXYPROPYL METHYLCELLULOSE, AND METHOD OF PRODUCING HYDROXYPROPYL METHYLCELLULOSE
5y 8m to grant Granted Apr 21, 2026
Patent 12599150
HIGHLY EMULSIFIABLE ALBUMEN HYDROLYSATE
4y 10m to grant Granted Apr 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
26%
Grant Probability
56%
With Interview (+30.1%)
4y 2m (~1y 12m remaining)
Median Time to Grant
Low
PTA Risk
Based on 636 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month